vs
Fidelis Insurance Holdings Ltd（FIHL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Fidelis Insurance Holdings Ltd的季度营收约是Royalty Pharma plc的1.0倍（$651.9M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 20.0%，领先14.4%），Royalty Pharma plc同比增速更快（4.8% vs -5.0%）
Fidelis Insurance Holdings Ltd是总部位于百慕大的全球特种保险与再保险服务商，提供财产、意外伤害、海事、航空等领域的定制化风险保障方案，服务范围覆盖北美、欧洲等地区的企业及机构客户。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FIHL vs RPRX — 直观对比
营收规模更大
FIHL
是对方的1.0倍
$622.0M
营收增速更快
RPRX
高出9.8%
-5.0%
净利率更高
RPRX
高出14.4%
20.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $651.9M | $622.0M |
| 净利润 | $130.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 24.7% | 62.4% |
| 净利率 | 20.0% | 34.4% |
| 营收同比 | -5.0% | 4.8% |
| 净利润同比 | 29.7% | 2.9% |
| 每股收益（稀释后） | $1.24 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIHLRPRX
| Q4 25 | — | $622.0M | ||
| Q3 25 | $651.9M | $609.3M | ||
| Q2 25 | $589.3M | $578.7M | ||
| Q1 25 | $658.4M | $568.2M | ||
| Q4 24 | — | $593.6M | ||
| Q3 24 | $686.1M | $564.7M | ||
| Q2 24 | $540.1M | $537.3M | ||
| Q1 24 | $520.0M | $568.0M |
净利润FIHLRPRX
| Q4 25 | — | $214.2M | ||
| Q3 25 | $130.5M | $288.2M | ||
| Q2 25 | $19.7M | $30.2M | ||
| Q1 25 | $-42.5M | $238.3M | ||
| Q4 24 | — | $208.2M | ||
| Q3 24 | $100.6M | $544.0M | ||
| Q2 24 | $53.7M | $102.0M | ||
| Q1 24 | $81.2M | $4.8M |
营业利润率FIHLRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | 24.7% | 70.1% | ||
| Q2 25 | 3.8% | 36.3% | ||
| Q1 25 | -7.6% | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 11.6% | 50.2% | ||
| Q1 24 | 18.3% | -13.0% |
净利率FIHLRPRX
| Q4 25 | — | 34.4% | ||
| Q3 25 | 20.0% | 47.3% | ||
| Q2 25 | 3.3% | 5.2% | ||
| Q1 25 | -6.5% | 41.9% | ||
| Q4 24 | — | 35.1% | ||
| Q3 24 | 14.7% | 96.3% | ||
| Q2 24 | 9.9% | 19.0% | ||
| Q1 24 | 15.6% | 0.8% |
每股收益（稀释后）FIHLRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | $1.24 | $0.67 | ||
| Q2 25 | $0.18 | $0.07 | ||
| Q1 25 | $-0.38 | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | $0.88 | $1.21 | ||
| Q2 24 | $0.46 | $0.23 | ||
| Q1 24 | $0.69 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $892.5M | $618.7M |
| 总债务越低越好 | $842.9M | $9.0B |
| 股东权益账面价值 | $2.4B | $9.7B |
| 总资产 | $12.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.35× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FIHLRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | $892.5M | $938.9M | ||
| Q2 25 | $919.4M | $631.9M | ||
| Q1 25 | $733.4M | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | $806.8M | $950.1M | ||
| Q2 24 | $628.6M | $1.8B | ||
| Q1 24 | $671.7M | $843.0M |
总债务FIHLRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | $842.9M | $8.9B | ||
| Q2 25 | $842.6M | $8.0B | ||
| Q1 25 | $449.1M | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | $448.8M | $7.6B | ||
| Q2 24 | $448.6M | $7.6B | ||
| Q1 24 | $448.4M | $6.1B |
股东权益FIHLRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | $2.4B | $9.6B | ||
| Q2 25 | $2.3B | $9.5B | ||
| Q1 25 | $2.4B | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | $2.6B | $10.3B | ||
| Q2 24 | $2.5B | $9.8B | ||
| Q1 24 | $2.5B | $9.9B |
总资产FIHLRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | $12.5B | $19.3B | ||
| Q2 25 | $13.0B | $18.3B | ||
| Q1 25 | $12.8B | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | $11.7B | $18.0B | ||
| Q2 24 | $11.9B | $17.7B | ||
| Q1 24 | $11.3B | $16.1B |
负债/权益比FIHLRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.35× | 0.93× | ||
| Q2 25 | 0.36× | 0.84× | ||
| Q1 25 | 0.19× | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.17× | 0.74× | ||
| Q2 24 | 0.18× | 0.78× | ||
| Q1 24 | 0.18× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $155.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $154.6M | — |
| 自由现金流率自由现金流/营收 | 23.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.19× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-320.9M | — |
8季度趋势，按日历期对齐
经营现金流FIHLRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | $155.2M | $702.6M | ||
| Q2 25 | $-359.2M | $364.0M | ||
| Q1 25 | $-433.1M | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | $318.9M | $703.6M | ||
| Q2 24 | $208.5M | $658.2M | ||
| Q1 24 | $-35.3M | $664.6M |
自由现金流FIHLRPRX
| Q4 25 | — | — | ||
| Q3 25 | $154.6M | — | ||
| Q2 25 | $-359.3M | — | ||
| Q1 25 | $-433.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $317.2M | — | ||
| Q2 24 | $206.6M | — | ||
| Q1 24 | $-35.6M | — |
自由现金流率FIHLRPRX
| Q4 25 | — | — | ||
| Q3 25 | 23.7% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -65.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 46.2% | — | ||
| Q2 24 | 38.3% | — | ||
| Q1 24 | -6.8% | — |
资本支出强度FIHLRPRX
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.1% | — |
现金转化率FIHLRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | 1.19× | 2.44× | ||
| Q2 25 | -18.23× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 3.17× | 1.29× | ||
| Q2 24 | 3.88× | 6.45× | ||
| Q1 24 | -0.43× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIHL
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
